Latest Breaking News On - Ionis pharmaceuticals company profile - Page 1 : vimarsana.com

Ionis Pharmaceuticals (NASDAQ:IONS) Reaches New 1-Year Low at $36 44

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $36.44 and last traded at $36.44, with a volume of 220851 shares traded. The stock had previously closed at $37.64. Analyst Ratings Changes Several equities analysts have recently weighed […]

United statesPiper sandlerJoseph baroldiWilliam blairHedge funds weigh in on ionis pharmaceuticalsNews ratings for ionis pharmaceuticals dailyIonis pharmaceuticalsIonis pharmaceuticals stock downMather groupSunbelt securities incWells fargo companySecurities exchange commissionIonis pharmaceuticals company profilePingora partnersIonis pharmaceuticals incGet free report

First Turn Management LLC Invests $18 04 Million in Ionis Pharmaceuticals, Inc (NASDAQ:IONS)

First Turn Management LLC Invests $18 04 Million in Ionis Pharmaceuticals, Inc (NASDAQ:IONS)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerJoseph baroldiWilliam blairQuarter for ionis pharmaceuticalsNeedham companySecurities exchange commissionIonis pharmaceuticalsIonis pharmaceuticals incLisanti capital growthFirst turn managementIonis pharmaceuticals company profileNews ratings for ionis pharmaceuticals dailyWells fargo companyRoyal bankIonis pharmaceuticals price performance

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Cut to $82 00 by Analysts at Wells Fargo & Company

Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Cut to $82 00 by Analysts at Wells Fargo & Company
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph baroldiPiper sandlerWilliam blairIonis pharmaceuticals company profileFifth third bancorpGrandfield doddIonis pharmaceuticals incInstitutional trading of ionis pharmaceuticalsIonis pharmaceuticalsWells fargo companyRoyal bankInsider transactions at ionis pharmaceuticalsIonis pharmaceuticals trading downNews ratings for ionis pharmaceuticals dailyFinancial services group inc

Wells Fargo & Company Trims Ionis Pharmaceuticals (NASDAQ:IONS) Target Price to $82 00

Wells Fargo & Company Trims Ionis Pharmaceuticals (NASDAQ:IONS) Target Price to $82 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerJoseph baroldiNeedham companyWells fargo companyIonis pharmaceuticalsIonis pharmaceuticals incGrandfield doddIonis pharmaceuticals company profileFifth third bancorpIonis pharmaceuticals price performanceThird bancorpSecurities exchange commissionAnalyst recommendations for ionis pharmaceuticalsVictory capital management incHedge funds weigh in on ionis pharmaceuticals

Ionis Pharmaceuticals (NASDAQ:IONS) Earns Buy Rating from Needham & Company LLC

Ionis Pharmaceuticals (NASDAQ:IONS) Earns Buy Rating from Needham & Company LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph baroldiPiper sandlerLisanti capital growthCharles schwab investment management incIonis pharmaceuticals incSecurities exchange commissionAnalyst recommendations for ionis pharmaceuticalsJpmorgan chase coNeedham companyIonis pharmaceuticalsIonis pharmaceuticals company profileWolfe researchIonis pharmaceuticals stock performanceNews ratings for ionis pharmaceuticals dailyGet free report